低分子肝素治疗急性脑梗死的临床研究

A study on the treatment of acute cerebral infarction with low molecular weight heparin

目的观察低分子肝素 (LMWH)治疗急性脑梗死的疗效及安全性。方法将 10 6例起病在 48小时内的急性脑梗死患者随机分为治疗组和对照组 ,分别给予低分子肝素及普通治疗。结果治疗组较对照组神经功能明显提高 (P <0 0 1) ,治疗期间无不良反应及并发症。结论低分子肝素治疗急性脑梗死是安全有效的。

Objective To study the effect and the safety of low molecular weight heparin (LMWH) on the treatment of acute cerebral infarction. Methods 106 cases with cerebral infarction within 48 hours of onset were randomly divided into LMWH treated group and control group. Results Neurological improvement was significantly higher in the LMWH treated group than in the control group ( P <0.01). There were no side-effects and complications during treatment. Conclusion The treatment of acute cerebral infarction with low molecular weight heparin is satisfaction.